Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ASND
Recent news which mentions ASND
< Previous
1
2
3
4
5
6
Next >
Expert Ratings for Ascendis Pharma
September 22, 2022
Tickers
ASND
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Ascendis Seeks FDA Nod For TransCon PTH In Adults With Hypoparathyroidism
August 31, 2022
Tickers
ASND
Tags
ASND
Health Care
Benzinga
From
Benzinga
Expert Ratings for Ascendis Pharma
August 30, 2022
Tickers
ASND
Tags
BZI/AAR
Analyst Ratings
ASND
From
Benzinga
Oppenheimer Maintains Outperform Rating for Ascendis Pharma: Here's What You Need To Know
August 11, 2022
Tickers
ASND
Tags
Market News
Benzinga
BZI/AAR/UPDATE
From
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Tickers
ADMP
AEMD
ALPN
ARDS
Tags
IBB
ASND
GSK
From
Benzinga
What 14 Analyst Ratings Have To Say About Ascendis Pharma
May 12, 2022
Tickers
ASND
Tags
Benzinga
Market News
BZI/AAR
From
Benzinga
Why Ascendis Pharma Stock Is Sinking Today
May 12, 2022
Tickers
ASND
Tags
Market News
Recent Press Releases
ASND
From
Motley Fool
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
IMMP
TFFP
ELDN
From
Benzinga
BofA Upgrades Ascendis Pharma After Promising TCP Phase 3 Data
March 15, 2022
Tickers
ASND
Tags
Price Target
Analyst Ratings
Analyst Color
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022
March 15, 2022
Tickers
AL
ASND
BIGC
BIVI
Tags
WAFD
O
Downgrades
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
Tickers
ASND
AVGR
CLSD
ERYP
Tags
GBS
Movers
FIXX
From
Benzinga
10 Biggest Price Target Changes For Monday
March 14, 2022
Tickers
ASND
AVDX
COCO
GIII
Tags
GLNG
Benzinga
Market News
From
Benzinga
Ascendis Pharma's Hypoparathyroidism Trial Meets Primary, Secondary Endpoints
March 14, 2022
Tickers
ASND
Tags
Health Care
News
ASND
From
Benzinga
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
Tickers
AKBA
AMLX
ARNA
ASND
Tags
Stocks to Buy
TERN
Market News
From
InvestorPlace
Expert Ratings For Ascendis Pharma
March 07, 2022
Tickers
ASND
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
March 03, 2022
Tickers
AMPE
ASND
ATRS
BGNE
Tags
NCNA
Market News
TCDA
From
Benzinga
Earnings Scheduled For March 2, 2022
March 02, 2022
Tickers
AEO
AI
AMRX
ANF
Tags
DLTR
SUPV
Earnings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
March 01, 2022
Tickers
ACLX
ACVA
ALNY
AMED
Tags
VTRS
AMP
ONTX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
Tickers
AGNC
ALL
ANET
ASND
Tags
USB
G
DFS
From
Benzinga
Where Ascendis Pharma Stands With Analysts
January 27, 2022
Tickers
ASND
Tags
ASND
Analyst Ratings
BZI/AAR
From
Benzinga
Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval
January 13, 2022
Tickers
ASND
Tags
Health Care
News
ASND
From
Benzinga
Where Ascendis Pharma Stands With Analysts
January 06, 2022
Tickers
ASND
Tags
Market News
Benzinga
ASND
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
Tickers
ADGI
ADT
AEIS
AKAM
Tags
DG
CAR
LAW
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
Tickers
ALLE
ALLT
AMPL
APLS
Tags
GT
Benzinga
LANC
From
Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
Tickers
ASND
BMY
CADL
CNTB
Tags
Penny Stocks
Small Cap
REGN
From
Benzinga
Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks
November 19, 2021
Tickers
ASND
Tags
FDA
Briefs
News
From
Benzinga
10 Biggest Price Target Changes For Monday
November 15, 2021
Tickers
ASND
BTAI
CARG
EVGO
Tags
BTAI
Benzinga
Market News
From
Benzinga
Analyst Ratings For Ascendis Pharma
November 11, 2021
Tickers
ASND
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
ASND
Tags
Market News
ASND
Recent Press Releases
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
October 20, 2021
Tickers
AGL
APO
ARRY
ASND
Tags
FSLR
JSPR
SEDG
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today